US Patent Issued to Amgen, AMGEN RESEARCH (MUNICH) on March 25 for "Bispecific antibody construct directed to MUC17 and CD3" (German, American Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,404, issued on March 25, was assigned to Amgen Inc. (Thousand Oaks, Calif.) and AMGEN RESEARCH (MUNICH) GMBH (Munich).

"Bispecific antibody construct directed to MUC17 and CD3" was invented by Tobias Raum (Munich), Tara Arvedson (Thousand Oaks, Calif.), Julie Bailis (Thousand Oaks, Calif.), Christoph Dahlhoff (Munich), Sandra Ross (Thousand Oaks, Calif.), Irwin Chen (Thousand Oaks, Calif.), Claudia Blumel (Munich), Elisabeth Nahrwold (Munich), Jochen Pendzialek (Munich) and Joachim Wahl (Munich).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides bispecific antibody constructs characterized by comprising a first domain bind...